FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 326:1456-1463 May 28, 1992 Number 22 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

Abstract

BACKGROUND AND METHODS. Most hemangiomas are small, harmless birthmarks that appear soon after birth, proliferate for 8 to 18 months, and then slowly regress over the next 5 to 8 years, leaving normal or slightly blemished skin. In rare cases, hemangiomas can endanger vital structures, with a mortality of up to 60 percent. About a third of these life-threatening hemangiomas respond to treatment with corticosteroids, but for the others there is no safe and effective treatment. We evaluated the effects of daily subcutaneous injections of interferon alfa-2a (up to 3 million units per square meter of body-surface area) in 20 neonates and infants with life-threatening or vision-threatening hemangiomas that failed to respond to corticosteroid therapy. RESULTS. In 18 of the 20 patients the hemangiomas regressed by 50 percent or more after an average of 7.8 months of treatment (range, 2 to 13). One infant died of refractory proliferation of a lesion and consumptive coagulopathy. The condition of three other patients who had large hemangiomas associated with consumptive coagulopathies that were unresponsive to conventional therapies stabilized after seven days of treatment with interferon alfa-2a alone. Transient side effects of treatment with interferon alfa-2a included fever, neutropenia (one patient), and skin necrosis (one patient). No long-term toxicity has been observed after a mean follow-up of 16 months. CONCLUSIONS. Interferon alfa-2a appears to induce the early regression of life-threatening corticosteroid-resistant hemangiomas of infancy.

Source Information

Division of Hematology and Oncology, Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02115.

This article has been cited by other articles:

• Sans, V., de la Roque, E. D., Berge, J., Grenier, N., Boralevi, F., Mazereeuw-Hautier, J., Lipsker, D., Dupuis, E., Ezzedine, K., Vergnes, P., Taieb, A., Leaute-Labreze, C. (2009). Propranolol for Severe Infantile Hemangiomas: Follow-Up Report. Pediatrics 124: e423-e431 [Abstract] [Full Text]  
• Dompmartin, A., Acher, A., Thibon, P., Tourbach, S., Hermans, C., Deneys, V., Pocock, B., Lequerrec, A., Labbe, D., Barrellier, M.-T., Vanwijck, R., Vikkula, M., Boon, L. M. (2008). Association of Localized Intravascular Coagulopathy With Venous Malformations. Arch Dermatol 144: 873-877 [Abstract] [Full Text]  
• Leaute-Labreze, C., Dumas de la Roque, E., Hubiche, T., Boralevi, F., Thambo, J.-B., Taieb, A. (2008). Propranolol for Severe Hemangiomas of Infancy. NEJM 358: 2649-2651 [Full Text]  
• Denny, M. F., Thacker, S., Mehta, H., Somers, E. C., Dodick, T., Barrat, F. J., McCune, W. J., Kaplan, M. J. (2007). Interferon-{alpha} promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 110: 2907-2915 [Abstract] [Full Text]  
• Sundine, M. J., Wirth, G. A. (2007). Hemangiomas: An Overview. CLIN PEDIATR 46: 206-221  
• Pauzner, R., Mayan, H., Waizman, A., Rozenman, J., Farfel, Z. (2007). Successful Thalidomide Treatment of Persistent Chylous Pleural Effusion. ANN INTERN MED 146: 75-76 [Full Text]  
• Durairaj, V. D. (2006). Treatment of deep orbital hemangiomas of infancy: an overview.. Arch Facial Plast Surg 8: 217-220 [Full Text]  
• Kurup, A., Lin, C.-W., Murry, D. J., Dobrolecki, L., Estes, D., Yiannoutsos, C. T., Mariano, L., Sidor, C., Hickey, R., Hanna, N. (2006). Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University. Ann Oncol 17: 97-103 [Abstract] [Full Text]  
• Smolinski, K. N., Yan, A. C. (2005). Hemangiomas of Infancy: Clinical and Biological Characteristics. CLIN PEDIATR 44: 747-766 [Abstract]  
• Schwartz, J. D., Sung, M., Schwartz, M., Lehrer, D., Mandeli, J., Liebes, L., Goldenberg, A., Volm, M. (2005). Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon-{alpha}2a upon Progression. The Oncologist 10: 718-727 [Abstract] [Full Text]  
• Thomas, R. F., Hornung, R. L., Manning, S. C., Perkins, J. A. (2005). Hemangiomas of Infancy: Treatment of Ulceration in the Head and Neck. Arch Facial Plast Surg 7: 312-315 [Abstract] [Full Text]  
• Streck, C. J., Dickson, P. V., Ng, C. Y.C., Zhou, J., Gray, J. T., Nathwani, A. C., Davidoff, A. M. (2005). Adeno-Associated Virus Vector-Mediated Systemic Delivery of IFN-{beta} Combined with Low-Dose Cyclophosphamide Affects Tumor Regression in Murine Neuroblastoma Models. Clin. Cancer Res. 11: 6020-6029 [Abstract] [Full Text]  
• Schultz, K., Rosenberg, A. E., Ebb, D. H., Mankin, H. J. (2005). Lower-Extremity Lymphangiomatosis. A Case Report with a Seventeen-Year Follow-up. JBJS 87: 162-167 [Full Text]  
• Koster, A., van Krieken, J. H.J.M., MacKenzie, M. A., Schraders, M., Borm, G. F., van der Laak, J. A.W.M., Leenders, W., Hebeda, K., Raemaekers, J. M.M. (2005). Increased Vascularization Predicts Favorable Outcome in Follicular Lymphoma. Clin. Cancer Res. 11: 154-161 [Abstract] [Full Text]  
• Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., De Bruijn, E. A. (2004). Vascular Endothelial Growth Factor and Angiogenesis. Pharmacol. Rev. 56: 549-580 [Abstract] [Full Text]  
• Palamara, F., Meindl, S., Holcmann, M., Luhrs, P., Stingl, G., Sibilia, M. (2004). Identification and Characterization of pDC-Like Cells in Normal Mouse Skin and Melanomas Treated with Imiquimod. J. Immunol. 173: 3051-3061 [Abstract] [Full Text]  
• Metry, D. W., Hawrot, A., Altman, C., Frieden, I. J. (2004). Association of Solitary, Segmental Hemangiomas of the Skin With Visceral Hemangiomatosis. Arch Dermatol 140: 591-596 [Abstract] [Full Text]  
• Mulliken, J. B., Anupindi, S., Ezekowitz, R. A. B., Mihm, M. C. Jr. (2004). Case 13-2004 - A Newborn Girl with a Large Cutaneous Lesion, Thrombocytopenia, and Anemia. NEJM 350: 1764-1775 [Full Text]  
• Rini, B. I., Halabi, S., Taylor, J., Small, E. J., Schilsky, R. L. (2004). Cancer and Leukemia Group B 90206: A Randomized Phase III Trial of Interferon-{alpha} or Interferon-{alpha} Plus Anti-Vascular Endothelial Growth Factor Antibody (Bevacizumab) in Metastatic Renal Cell Carcinoma. Clin. Cancer Res. 10: 2584-2586 [Abstract] [Full Text]  
• Bocci, G., Francia, G., Man, S., Lawler, J., Kerbel, R. S. (2003). Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc. Natl. Acad. Sci. USA 100: 12917-12922 [Abstract] [Full Text]  
• Lara, P. N. Jr., Quinn, D. I., Margolin, K., Meyers, F. J., Longmate, J., Frankel, P., Mack, P. C., Turrell, C., Valk, P., Rao, J., Buckley, P., Wun, T., Gosselin, R., Galvin, I., Gumerlock, P. H., Lenz, H. J., Doroshow, J. H., Gandara, D. R. (2003). SU5416 Plus Interferon {alpha} in Advanced Renal Cell Carcinoma: A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition. Clin. Cancer Res. 9: 4772-4781 [Abstract] [Full Text]  
• Beerepoot, L. V., Witteveen, E. O., Groenewegen, G., Fogler, W. E., Sim, B. K. L., Sidor, C., Zonnenberg, B. A., Schramel, F., Gebbink, M. F. B. G., Voest, E. E. (2003). Recombinant Human Angiostatin by Twice-Daily Subcutaneous Injection in Advanced Cancer: A Pharmacokinetic and Long-Term Safety Study. Clin. Cancer Res. 9: 4025-4033 [Abstract] [Full Text]  
• Nambu, H., Nambu, R., Melia, M., Campochiaro, P. A. (2003). Combretastatin A-4 Phosphate Suppresses Development and Induces Regression of Choroidal Neovascularization. IOVS 44: 3650-3655 [Abstract] [Full Text]  
• Bentley, J. M., Barankin, B., Guenther, L. C. (2003). A Review of Common Pediatric Lip Lesions: Herpes Simplex/Recurrent Herpes Labialis, Impetigo, Mucoceles, and Hemangiomas. CLIN PEDIATR 42: 475-482 [Abstract]  
• Biban, P, Emir, S, Akyuz, C (2003). Kasabach-Merritt syndrome and interferon alpha: still a controversial issue * Authors' reply. Arch. Dis. Child. 88: 645-646 [Full Text]  
• Gomez, D., Reich, N. C. (2003). Stimulation of Primary Human Endothelial Cell Proliferation by IFN. J. Immunol. 170: 5373-5381 [Abstract] [Full Text]  
• Lockhart, A. C., Braun, R. D., Yu, D., Ross, J. R., Dewhirst, M. W., Humphrey, J. S., Thompson, S., Williams, K. M., Klitzman, B., Yuan, F., Grichnik, J. M., Proia, A. D., Conway, D. A., Hurwitz, H. I. (2003). Reduction of Wound Angiogenesis in Patients Treated with BMS-275291, a Broad Spectrum Matrix Metalloproteinase Inhibitor. Clin. Cancer Res. 9: 586-593 [Abstract] [Full Text]  
• Bamberger, E S, Perrett, C W (2002). Angiogenesis in epithelian ovarian cancer. Mol. Pathol. 55: 348-359 [Abstract] [Full Text]  
• Bocci, G., Nicolaou, K. C., Kerbel, R. S. (2002). Protracted Low-Dose Effects on Human Endothelial Cell Proliferation and Survival in Vitro Reveal a Selective Antiangiogenic Window for Various Chemotherapeutic Drugs. Cancer Res. 62: 6938-6943 [Abstract] [Full Text]  
• Dorrell, M. I., Aguilar, E., Friedlander, M. (2002). Retinal Vascular Development Is Mediated by Endothelial Filopodia, a Preexisting Astrocytic Template and Specific R-Cadherin Adhesion. IOVS 43: 3500-3510 [Abstract] [Full Text]  
• Huang, S. F., Kim, S.-J., Lee, A. T., Karashima, T., Bucana, C., Kedar, D., Sweeney, P., Mian, B., Fan, D., Shepherd, D., Fidler, I. J., Dinney, C. P., Killion, J. J. (2002). Inhibition of Growth and Metastasis of Orthotopic Human Prostate Cancer in Athymic Mice by Combination Therapy with Pegylated Interferon-{alpha}-2b and Docetaxel. Cancer Res. 62: 5720-5726 [Abstract] [Full Text]  
• Folkman, J. (2002). The Podium. J Law Med Ethics 30: 361-366  
• Hammond, E. M., Giaccia, A. J., Browder, T., Folkman, J., Hahnfeldt, P., Heymach, J., Hlatky, L., Kieran, M., Rogers, M. S., Kerbel, Robert. S., Yu, J. L., Rak, J., Coomber, B. (2002). Antiangiogenic Therapy and p53. Science 297: 471a-471 [Abstract] [Full Text]  
• Yu, J. L., Rak, J. W., Coomber, B. L., Hicklin, D. J., Kerbel, R. S. (2002). Effect of p53 Status on Tumor Response to Antiangiogenic Therapy. Science 295: 1526-1528 [Abstract] [Full Text]  
• Hesselmann, S, Micke, O, Marquardt, T, Baas, S, Bramswig, J H, Harms, E, Willich, N (2002). Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha. Br. J. Radiol. 75: 180-184 [Abstract] [Full Text]  
• Yu, Y., Varughese, J., Brown, L. F., Mulliken, J. B., Bischoff, J. (2001). Increased Tie2 Expression, Enhanced Response to Angiopoietin-1, and Dysregulated Angiopoietin-2 Expression in Hemangioma-Derived Endothelial Cells. Am. J. Pathol. 159: 2271-2280 [Abstract] [Full Text]  
• Olson, K. A., Byers, H. R., Key, M. E., Fett, J. W. (2001). Prevention of Human Prostate Tumor Metastasis in Athymic Mice by Antisense Targeting of Human Angiogenin. Clin. Cancer Res. 7: 3598-3605 [Abstract] [Full Text]  
• Kerbel, R. S. (2001). Clinical Trials of Antiangiogenic Drugs: Opportunities, Problems, and Assessment of Initial Results. JCO 19: 45s-51 [Full Text]  
• Hillman, J. D., Peng, A. T., Gilliam, A. C., Remick, S. C. (2001). Treatment of Kaposi Sarcoma With Oral Administration of Shark Cartilage in a Human Herpesvirus 8-Seropositive, Human Immunodeficiency Virus-Seronegative Homosexual Man. Arch Dermatol 137: 1149-1152 [Full Text]  
• Slaton, J. W., Karashima, T., Perrotte, P., Inoue, K., Kim, S. J., Izawa, J., Kedar, D., McConkey, D. J., Millikan, R., Sweeney, P., Yoshikawa, C., Shuin, T., Dinney, C. P. N. (2001). Treatment with Low-Dose Interferon-{alpha} Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder. Clin. Cancer Res. 7: 2840-2853 [Abstract] [Full Text]  
• Mori, K., Ando, A., Gehlbach, P., Nesbitt, D., Takahashi, K., Goldsteen, D., Penn, M., Chen, C. T., Mori, K., Melia, M., Phipps, S., Moffat, D., Brazzell, K., Liau, G., Dixon, K. H., Campochiaro, P. A. (2001). Inhibition of Choroidal Neovascularization by Intravenous Injection of Adenoviral Vectors Expressing Secretable Endostatin. Am. J. Pathol. 159: 313-320 [Abstract] [Full Text]  
• Ramsey, P. S., Danilenko, D. R., Derleth, D. P. (2001). Radiological Case of the Month. Arch Pediatr Adolesc Med 155: 733-734 [Full Text]  
• Bree, A. F., Siegfried, E., Sotelo-Avila, C., Nahass, G. (2001). Infantile Hemangiomas: Speculation on Placental Trophoblastic Origin. Arch Dermatol 137: 573-577 [Abstract] [Full Text]  
• Weissleder, R., Mahmood, U. (2001). Molecular Imaging. Radiology 219: 316-333 [Abstract] [Full Text]  
• Yu, J. L., Rak, J. W., Carmeliet, P., Nagy, A., Kerbel, R. S., Coomber, B. L. (2001). Heterogeneous Vascular Dependence of Tumor Cell Populations. Am. J. Pathol. 158: 1325-1334 [Abstract] [Full Text]  
• Niemelä, M., Mäenpää, H., Salven, P., Summanen, P., Poussa, K., Laatikainen, L., Jääskeläinen, J., Joensuu, H. (2001). Interferon {{alpha}}-2a Therapy in 18 Hemangioblastomas. Clin. Cancer Res. 7: 510-516 [Abstract] [Full Text]  
• Fidler, I. J. (2000). Regulation of Neoplastic Angiogenesis. J Natl Cancer Inst Monogr 2000: 10-14 [Abstract] [Full Text]  
• STUEBIGER, N., KOETTER, I., ZIERHUT, M. (2000). Complete regression of retinal neovascularisation after therapy with interferon alfa in Behcet's disease. Br J Ophthalmol 84: 1432g-1432 [Full Text]  
• Hong, Y.-K., Chung, D.-S., Joe, Y.-A., Yang, Y.-J., Kim, K.-M., Park, Y.-S., Yung, W. K. A., Kang, J.-K. (2000). Efficient Inhibition of In Vivo Human Malignant Glioma Growth and Angiogenesis by Interferon-{beta} Treatment at Early Stage of Tumor Development. Clin. Cancer Res. 6: 3354-3360 [Abstract] [Full Text]  
• Metry, D. W., Hebert, A. A. (2000). Benign Cutaneous Vascular Tumors of Infancy: When to Worry, What to Do. Arch Dermatol 136: 905-914 [Abstract] [Full Text]  
• Griffioen, A. W., Molema, G. (2000). Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation. Pharmacol. Rev. 52: 237-268 [Abstract] [Full Text]  
• ROHAN, R. M., FERNANDEZ, A., UDAGAWA, T., YUAN, J., D’AMATO, R. J. (2000). Genetic heterogeneity of angiogenesis in mice. FASEB J. 14: 871-876 [Abstract] [Full Text]  
• Kerbel, R. S. (2000). Tumor angiogenesis: past, present and the near future. Carcinogenesis 21: 505-515 [Abstract] [Full Text]  
• Donnelly, L. F., Adams, D. M., Bisset, G. S. III (2000). Vascular Malformations and Hemangiomas: A Practical Approach in a Multidisciplinary Clinic. Am. J. Roentgenol. 174: 597-608 [Full Text]  
• Roebuck, D. J., Ahuja, A. T. (2000). Hemangioendothelioma of the Parotid Gland in Infants: Sonography and Correlative MR Imaging. Am. J. Neuroradiol. 21: 219-223 [Abstract] [Full Text]  
• MATSUDA, H., HAYASHI, K., ARAKAWA, K., NAITOH, M., KUBOTA, E., HONDA, M., MATSUMOTO, A., SUZUKI, H., YAMAMOTO, T., KAJIYA, F., SARUTA, T. (1999). Zonal Heterogeneity in Action of Angiotensin-Converting Enzyme Inhibitor on Renal Microcirculation: Role of Intrarenal Bradykinin. J. Am. Soc. Nephrol. 10: 2272-2282 [Abstract] [Full Text]  
• Slaton, J. W., Perrotte, P., Inoue, K., Dinney, C. P. N., Fidler, I. J. (1999). Interferon-{{alpha}}-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule. Clin. Cancer Res. 5: 2726-2734 [Abstract] [Full Text]  
• Drolet, B. A., Esterly, N. B., Frieden, I. J. (1999). Hemangiomas in Children. NEJM 341: 173-181 [Full Text]  
• RADZIWILL, A. J, COURVOISIER, S. (1999). Severe necrotising cutaneous lesions complicating treatment with interferon beta -1a. J. Neurol. Neurosurg. Psychiatry 67: 115-115 [Full Text]  
• Rozera, C., Carlei, D., Lollini, P. L., De Giovanni, C., Musiani, P., Di Carlo, E., Belardelli, F., Ferrantini, M. (1999). Interferon (IFN)-ß Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-{alpha} : Differential Effects on Tumorigenicity and Host Response. Am. J. Pathol. 154: 1211-1222 [Abstract] [Full Text]  
• Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., Dinney, C. P. N. (1999). Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice. Clin. Cancer Res. 5: 257-264 [Abstract] [Full Text]  
• Lingen, M.W. (1999). Angiogenesis in the Development of Head and Neck Cancer and Its Inhibition By Chemopreventive Agents. CROBM 10: 153-164 [Abstract] [Full Text]  
• Greinwald, J. H. Jr, Burke, D. K., Bonthius, D. J., Bauman, N. M., Smith, R. J. H. (1999). An Update on the Treatment of Hemangiomas in Children With Interferon Alfa-2a. Arch Otolaryngol Head Neck Surg 125: 21-27 [Abstract] [Full Text]  
• Der, S. D., Zhou, A., Williams, B. R. G., Silverman, R. H. (1998). Identification of genes differentially regulated by interferon alpha , beta , or gamma  using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95: 15623-15628 [Abstract] [Full Text]  
• Ji, W.-r., Castellino, F. J., Chang, Y., Deford, M. E., Gray, H., Villarreal, X., Kondri, M. E., Marti, D. N., Llinás, M., Schaller, J., Kramer, R. A., Trail, P. A. (1998). Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J. 12: 1731-1738 [Abstract] [Full Text]  
• Li, V. W., Jaffe, M. P., Li, W. W., Haynes, H. A. (1998). Off-Label Dermatologic Therapies: Usage, Risks, and Mechanisms. Arch Dermatol 134: 1449-1454 [Abstract] [Full Text]  
• Clymer, M. A., Fortune, D. S., Reinisch, L., Toriumi, D. M., Werkhaven, J. A., Ries, W. R. (1998). Interstitial Nd:YAG Photocoagulation for Vascular Malformations and Hemangiomas in Childhood. Arch Otolaryngol Head Neck Surg 124: 431-436 [Abstract] [Full Text]  
• Tamayo, L., Ortiz, D. M., Orozco-Covarrubias, L., Duran-McKinster, C., Mora, M. A., Avila, E., Teixeira, F., Ruiz-Maldonado, R. (1997). Therapeutic Efficacy of Interferon Alfa-2b in Infants With Life-Threatening Giant Hemangiomas. Arch Dermatol 133: 1567-1571 [Abstract]  
• Vin-Christian, K., McCalmont, T. H., Frieden, I. J. (1997). Kaposiform Hemangioendothelioma: An Aggressive, Locally Invasive Vascular Tumor That Can Mimic Hemangioma of Infancy. Arch Dermatol 133: 1573-1578 [Abstract]  
• Frieden, I. J. (1997). Which Hemangiomas to Treat--and How?. Arch Dermatol 133: 1593-1595 [Abstract]  
• Wadler, S., Schwartz, E. L. (1997). New Advances in Interferon Therapy of Cancer. The Oncologist 2: 254-267 [Abstract] [Full Text]  
• Pharmacological Therapy for Macular Degeneration S, (1997). Interferon Alfa-2a Is Ineffective for Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Results of a Prospective Randomized Placebo-Controlled Clinical Trial. Arch Ophthalmol 115: 865-872 [Abstract]  
• Kunishige, M., Azuma, H., Masuda, K., Shigekiyo, T., Arii, Y., Kawai, H., Saito, S., Kunishige, M. (1997). Interferon Alpha-2a Therapy for Disseminated Intravascular Coagulation in a Patient with Blue Rubber Bleb Nevus Syndrome: A Case Report. ANGIOLOGY 48: 273-277 [Abstract]  
• Folkman, J. (1995). Clinical Applications of Research on Angiogenesis. NEJM 333: 1757-1763 [Full Text]  
• Ezekowitz, A., Mulliken, J., Folkman, J. (1995). Additional Corrections: Interferon for Hemangiomas of Infancy. NEJM 333: 595-596 [Full Text]  
• MacArthur, C. J., Senders, C. W., Katz, J. (1995). The Use of Interferon Alfa-2a for Life-Threatening Hemangiomas. Arch Otolaryngol Head Neck Surg 121: 690-693 [Abstract]  
• D'Amico, D. J. (1994). Diseases of the Retina. NEJM 331: 95-106 [Full Text]  
• Allen, P.W. (1994). Invited Review : Three New Vascular Tumors Tufted Angioma, Kaposiform Infantile Hemangioendothelioma, and Proliferative Cutaneous Angiomatosis. INT J SURG PATHOL 2: 63-71 [Abstract]  
• Hendren, W. H. (1994). Pediatric Surgery: Then and Now. Arch Surg 129: 345-352 [Abstract]  
• Guyer, D. R., Adamis, A. P., Gragoudas, E. S., Folkman, J., Slakter, J. S., Yannuzzi, L. A. (1992). Systemic Antiangiogenic Therapy for Choroidal Neovascularization: What Is the Role of Interferon Alfa?. Arch Ophthalmol 110: 1383-1384 [Abstract]  
• Otani, A., Slike, B. M., Dorrell, M. I., Hood, J., Kinder, K., Ewalt, K. L., Cheresh, D., Schimmel, P., Friedlander, M. (2002). A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc. Natl. Acad. Sci. USA 99: 178-183 [Abstract] [Full Text]  
• Kassarjian, A., Dubois, J., Burrows, P. E. (2002). Angiographic Classification of Hepatic Hemangiomas in Infants. Radiology 222: 693-698 [Abstract] [Full Text]